• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在非小细胞肺癌细胞中,CCAR2缺陷在褪黑素存在的情况下增强了基因毒性应激诱导的细胞凋亡。

CCAR2 deficiency augments genotoxic stress-induced apoptosis in the presence of melatonin in non-small cell lung cancer cells.

作者信息

Kim Wootae, Jeong Joo-Won, Kim Ja-Eun

机构信息

Department of Pharmacology, School of Medicine, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul, 130-701, Republic of Korea.

出版信息

Tumour Biol. 2014 Nov;35(11):10919-29. doi: 10.1007/s13277-014-2370-6. Epub 2014 Aug 2.

DOI:10.1007/s13277-014-2370-6
PMID:25085583
Abstract

Melatonin exhibits oncostatic activity in several cancers but does not lead to cytotoxicity in estrogen receptor (ER)-negative non-small cell lung cancers (NSCLCs). In an effort to overcome the melatonin resistance of these cancers, we investigated whether cell cycle and apoptosis regulator 2 (CCAR2) depletion would promote apoptosis following genotoxic stress in melatonin-resistant cancer cells. Ordinarily, the NSCLC cell lines A549 and A427 did not undergo cell death following melatonin treatment for short period. These cell lines were irradiated with UV, a source of genotoxic damage, to trigger apoptotic signaling. Treatment with melatonin prior to irradiation did not produce any significant change in apoptosis. By contrast, in CCAR2-deficient cells, melatonin treatment increased apoptosis induced by genotoxic stress; this effect was dependent on the dose of melatonin. The increase in apoptosis in CCAR2-deficient cells was not dependent on SIRT1. The results indicate that CCAR2 is critical for maintaining cell survival in the presence of melatonin under genotoxic stress. Furthermore, CCAR2 is overexpressed in NSCLC; therefore, melatonin could be used as a potential supplement to classical anticancer drugs in therapies against CCAR2-deficient cancers.

摘要

褪黑素在多种癌症中表现出抑癌活性,但对雌激素受体(ER)阴性的非小细胞肺癌(NSCLC)不会产生细胞毒性。为了克服这些癌症的褪黑素耐药性,我们研究了在耐褪黑素的癌细胞中,敲低细胞周期和凋亡调节因子2(CCAR2)是否会在基因毒性应激后促进细胞凋亡。通常情况下,NSCLC细胞系A549和A427在短期褪黑素处理后不会发生细胞死亡。用紫外线(一种基因毒性损伤源)照射这些细胞系,以触发凋亡信号。照射前用褪黑素处理对细胞凋亡没有产生任何显著变化。相比之下,在CCAR2缺陷细胞中,褪黑素处理增加了基因毒性应激诱导的细胞凋亡;这种效应取决于褪黑素的剂量。CCAR2缺陷细胞中细胞凋亡的增加不依赖于沉默调节蛋白1(SIRT1)。结果表明,在基因毒性应激下,CCAR2对于在褪黑素存在的情况下维持细胞存活至关重要。此外,CCAR2在NSCLC中过表达;因此,褪黑素可作为一种潜在的补充药物,与传统抗癌药物联合用于治疗CCAR2缺陷型癌症。

相似文献

1
CCAR2 deficiency augments genotoxic stress-induced apoptosis in the presence of melatonin in non-small cell lung cancer cells.在非小细胞肺癌细胞中,CCAR2缺陷在褪黑素存在的情况下增强了基因毒性应激诱导的细胞凋亡。
Tumour Biol. 2014 Nov;35(11):10919-29. doi: 10.1007/s13277-014-2370-6. Epub 2014 Aug 2.
2
Anti-cancer effects of REIC/Dkk-3-encoding adenoviral vector for the treatment of non-small cell lung cancer.REIC/Dkk-3 编码腺病毒载体治疗非小细胞肺癌的抗癌作用。
PLoS One. 2014 Feb 3;9(2):e87900. doi: 10.1371/journal.pone.0087900. eCollection 2014.
3
Cell cycle and apoptosis regulator 2 at the interface between DNA damage response and cell physiology.细胞周期和凋亡调节因子 2 位于 DNA 损伤反应和细胞生理学的交界处。
Mutat Res Rev Mutat Res. 2018 Apr-Jun;776:1-9. doi: 10.1016/j.mrrev.2018.03.004. Epub 2018 Mar 19.
4
Methionine Aminopeptidase 2 as a Potential Therapeutic Target for Human Non-Small-Cell Lung Cancers.蛋氨酸氨肽酶2作为人类非小细胞肺癌的潜在治疗靶点
Adv Clin Exp Med. 2016 Jan-Feb;25(1):117-28. doi: 10.17219/acem/60715.
5
Evaluation of role of Notch3 signaling pathway in human lung cancer cells.Notch3信号通路在人肺癌细胞中的作用评估。
J Cancer Res Clin Oncol. 2016 May;142(5):981-93. doi: 10.1007/s00432-016-2117-4. Epub 2016 Feb 2.
6
Histone deacetylase 9 downregulation decreases tumor growth and promotes apoptosis in non-small cell lung cancer after melatonin treatment.褪黑素治疗后下调组蛋白去乙酰化酶 9 可减少非小细胞肺癌肿瘤生长并促进细胞凋亡。
J Pineal Res. 2019 Sep;67(2):e12587. doi: 10.1111/jpi.12587. Epub 2019 Jun 3.
7
Genetic determinants of pemetrexed responsiveness and nonresponsiveness in non-small cell lung cancer cells.非小细胞肺癌细胞中培美曲塞响应和无响应的遗传决定因素。
J Thorac Oncol. 2010 Aug;5(8):1143-51. doi: 10.1097/JTO.0b013e3181e0b954.
8
Human Noxin is an anti-apoptotic protein in response to DNA damage of A549 non-small cell lung carcinoma.人诺欣是一种抗凋亡蛋白,可响应 A549 非小细胞肺癌的 DNA 损伤。
Int J Cancer. 2014 Jun 1;134(11):2595-604. doi: 10.1002/ijc.28600. Epub 2013 Nov 29.
9
Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.BIRC6 蛋白在非小细胞肺癌中的高表达与癌症复发和化疗耐药有关。
J Thorac Oncol. 2013 Feb;8(2):161-70. doi: 10.1097/JTO.0b013e31827d5237.
10
CCAR2/DBC1 and Hsp60 Positively Regulate Expression of Survivin in Neuroblastoma Cells.CCAR2/DBC1 和 Hsp60 正向调节神经母细胞瘤细胞中 Survivin 的表达。
Int J Mol Sci. 2019 Jan 1;20(1):131. doi: 10.3390/ijms20010131.

引用本文的文献

1
CircKRT75 augments the cisplatin chemoresistance of nasopharyngeal carcinoma via targeting miR-659/CCAR2 axis.环状 RNA KRT75 通过靶向 miR-659/CCAR2 轴增强鼻咽癌的顺铂化疗耐药性。
J Mol Histol. 2024 Nov 29;56(1):9. doi: 10.1007/s10735-024-10287-1.
2
Protective effect of melatonin against methamphetamine-induced attention deficits through miR-181/SIRT1 axis in the prefrontal cortex.褪黑素通过 miR-181/SIRT1 轴在前额叶皮层对甲基苯丙胺引起的注意力缺陷的保护作用。
Mol Biol Rep. 2024 May 25;51(1):690. doi: 10.1007/s11033-024-09631-1.
3
Mechanistic insights into the dual role of CCAR2/DBC1 in cancer.

本文引用的文献

1
Molecular mechanisms of the pro-apoptotic actions of melatonin in cancer: a review.褪黑素在癌症中促凋亡作用的分子机制:综述。
Expert Opin Ther Targets. 2013 Dec;17(12):1483-96. doi: 10.1517/14728222.2013.834890. Epub 2013 Sep 14.
2
Expression of SIRT1 and DBC1 is associated with poor prognosis of soft tissue sarcomas.SIRT1 和 DBC1 的表达与软组织肉瘤的不良预后相关。
PLoS One. 2013 Sep 3;8(9):e74738. doi: 10.1371/journal.pone.0074738. eCollection 2013.
3
Acetylation status of P53 and the expression of DBC1, SIRT1, and androgen receptor are associated with survival in clear cell renal cell carcinoma patients.
深入了解 CCAR2/DBC1 在癌症中的双重作用的机制见解。
Exp Mol Med. 2023 Aug;55(8):1691-1701. doi: 10.1038/s12276-023-01058-1. Epub 2023 Aug 1.
4
Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities.褪黑素在癌症治疗中的应用:现有知识与未来机遇。
Molecules. 2021 Apr 25;26(9):2506. doi: 10.3390/molecules26092506.
5
An updated review of mechanistic potentials of melatonin against cancer: pivotal roles in angiogenesis, apoptosis, autophagy, endoplasmic reticulum stress and oxidative stress.褪黑素抗癌机制潜力的最新综述:在血管生成、细胞凋亡、自噬、内质网应激和氧化应激中的关键作用。
Cancer Cell Int. 2021 Mar 31;21(1):188. doi: 10.1186/s12935-021-01892-1.
6
CCAR1 and CCAR2 as gene chameleons with antagonistic duality: Preclinical, human translational, and mechanistic basis.CCAR1 和 CCAR2 作为具有拮抗双重性的基因变色龙:临床前、人体转化和机制基础。
Cancer Sci. 2020 Oct;111(10):3416-3425. doi: 10.1111/cas.14579. Epub 2020 Aug 9.
7
Integrative Analysis of Cancer Omics Data for Prognosis Modeling.癌症组学数据的综合分析用于预后建模。
Genes (Basel). 2019 Aug 9;10(8):604. doi: 10.3390/genes10080604.
8
Melatonin and non-small cell lung cancer: new insights into signaling pathways.褪黑素与非小细胞肺癌:信号通路的新见解
Cancer Cell Int. 2019 May 16;19:131. doi: 10.1186/s12935-019-0853-7. eCollection 2019.
9
CCAR2 negatively regulates IL-8 production in cervical cancer cells.CCAR2对宫颈癌细胞中白细胞介素-8的产生起负调控作用。
Oncotarget. 2017 Dec 13;9(1):1143-1155. doi: 10.18632/oncotarget.23199. eCollection 2018 Jan 2.
10
Melatonin for the prevention and treatment of cancer.褪黑素用于癌症的预防和治疗。
Oncotarget. 2017 Jun 13;8(24):39896-39921. doi: 10.18632/oncotarget.16379.
乙酰化状态的 P53 和 DBC1、SIRT1、雄激素受体的表达与透明细胞肾细胞癌患者的生存相关。
Pathology. 2013 Oct;45(6):574-80. doi: 10.1097/PAT.0b013e3283652c7a.
4
Expression of DBC1 and Androgen Receptor Predict Poor Prognosis in Diffuse Large B Cell Lymphoma.DBC1 和雄激素受体的表达预示弥漫性大 B 细胞淋巴瘤预后不良。
Transl Oncol. 2013 Jun 1;6(3):370-81. doi: 10.1593/tlo.13250. Print 2013 Jun.
5
SIRT1 inhibition by melatonin exerts antitumor activity in human osteosarcoma cells.褪黑素抑制 SIRT1 表达可增强人骨肉瘤细胞的抗肿瘤活性。
Eur J Pharmacol. 2013 Sep 5;715(1-3):219-29. doi: 10.1016/j.ejphar.2013.05.017. Epub 2013 May 29.
6
Melatonin reverses tunicamycin-induced endoplasmic reticulum stress in human hepatocellular carcinoma cells and improves cytotoxic response to doxorubicin by increasing CHOP and decreasing survivin.褪黑素逆转了衣霉素诱导的人肝癌细胞内质网应激,并通过增加 CHOP 和减少生存素来提高多柔比星的细胞毒性反应。
J Pineal Res. 2013 Sep;55(2):184-94. doi: 10.1111/jpi.12061. Epub 2013 May 25.
7
DBC1 (Deleted in Breast Cancer 1) modulates the stability and function of the nuclear receptor Rev-erbα.DBC1(乳腺癌 1 中缺失)调节核受体 Rev-erbα 的稳定性和功能。
Biochem J. 2013 May 1;451(3):453-61. doi: 10.1042/BJ20121085.
8
Deleted in breast cancer 1 (DBC1) deficiency results in apoptosis of breast cancer cells through impaired responses to UV-induced DNA damage.缺失乳腺癌 1 基因(DBC1)会导致乳腺癌细胞凋亡,这是由于其对紫外线诱导的 DNA 损伤的反应受损。
Cancer Lett. 2013 Jun 10;333(2):180-6. doi: 10.1016/j.canlet.2013.01.026. Epub 2013 Jan 22.
9
Expression of SIRT1 and DBC1 in Gastric Adenocarcinoma.SIRT1和DBC1在胃腺癌中的表达
Korean J Pathol. 2012 Dec;46(6):523-31. doi: 10.4132/KoreanJPathol.2012.46.6.523. Epub 2012 Dec 26.
10
DBC1 is over-expressed and associated with poor prognosis in colorectal cancer.DBC1 在结直肠癌中过表达,并与不良预后相关。
Int J Clin Oncol. 2014 Feb;19(1):106-12. doi: 10.1007/s10147-012-0506-5. Epub 2013 Jan 9.